A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory bowel disease from healthy control individuals.

Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

or IBD. “The researchers synthesized several compounds containing common secondary bile acids and compared their effects in a mouse model of acute colitis. They found that an orally administered ...

Preclinical models are simplified tools that help researchers study these complex interactions in a controlled manner and prioritize relevant biochemical pathways when developing IBD therapies ...

Using the three cytokines to trigger IBD-like conditions, the researchers examined whether a similar treatment of a commonly used cell line used to model IBD could produce a comparable response ...

In the guts of patients with inflammatory bowel disease (IBD), adenosine triphosphate (ATP) produced outside of cells leads to intestinal inflammation. Francisco Quintana, an immunologist and ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) ...

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

Share on Pinterest Scientists are working on a new test to predict colorectal cancer in IBD patients. South_agency/Getty Images People with inflammatory bowel disease (IBD) are at an increased ...